Not for ophthalmic, oral or intravaginal use, or for
use by patients with a hypersensitivity to any of
its components. In clinical studies, drug-related
side effects following the use of CUTIVATE Lotion
consisted primarily of localized burning and
stinging, and were usually mild and self-limiting.
No skin atrophy, changes in pigmentation, or
evidence of HPA-axis suppression were observed
following the use of CUTIVATE Lotion in these
studies. Adrenal suppression has been observed in
studies with other fluticasone propionate topical
formulations.
|